JPMorgan analyst Matthew Boss raised the firm’s price target on Bath & Body Works to $46 from $40 and keeps an Overweight rating on the shares. The firm adjusted price targets in the department store and specialty softline group ahead of the Q2 reports. JPMorgan’s fieldwork indicates a strong close to the quarter on a July consumer acceleration, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Strategic Initiatives and Growth Prospects Position Bath & Body Works Favorably in Specialty Retail
- Bath & Body Works Holds Annual Stockholders Meeting
- Bath & Body Works call volume above normal and directionally bullish
- Bath & Body Works price target lowered to $38 from $43 at Telsey Advisory
- Bath & Body Works price target lowered to $41 from $43 at Morgan Stanley